{"count": 6, "results": [{"_id": "32125970", "pmid": 32125970, "title": "A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex.", "journal": "Respir Med", "authors": ["Krymskaya VP", "Courtwright AM", "Fleck V", "Dorgan D", "Kotloff R", "McCormack FX", "Kreider M"], "date": "2020-03-01T00:00:00Z", "doi": "10.1016/j.rmed.2020.105898", "meta_date_publication": "2020 Mar", "meta_volume": "163", "meta_issue": "", "meta_pages": "105898", "score": 50272.586, "text_hl": "A phase II clinical trial of the Safety Of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ (SOS) in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Lymphangioleiomyomatosis</m> @DISEASE_MESH:D018192 @@@pulmonary lymphangioleiomyomatosis@@@ and with @DISEASE_Tuberous_Sclerosis @DISEASE_MESH:D014402 @@@tuberous sclerosis complex@@@.", "citations": {"NLM": "Krymskaya VP, Courtwright AM, Fleck V, Dorgan D, Kotloff R, McCormack FX, Kreider M. A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex. Respir Med. 2020 Mar;163():105898. PMID: 32125970", "BibTeX": "@article{32125970, title={A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex.}, author={Krymskaya VP and Courtwright AM and Fleck V and Dorgan D and Kotloff R and McCormack FX and Kreider M}, journal={Respir Med}, volume={163}, pages={105898}}"}}, {"_id": "25580270", "pmid": 25580270, "pmcid": "PMC4251421", "title": "Management of lymphangioleiomyomatosis", "journal": "F1000Prime Rep", "authors": ["Taveira-DaSilva AM", "Moss J"], "date": "2014-12-01T00:00:00Z", "doi": "10.12703/P6-116", "meta_date_publication": "2014", "meta_volume": "6", "meta_issue": "", "meta_pages": "116", "score": 50087.836, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ was also shown to reduce alveolar space enlargement in a @SPECIES_10090 @@@mouse@@@ model of @<m>DISEASE_Lymphangioleiomyomatosis</m> @DISEASE_MESH:D018192 @@@LAM@@@. ", "citations": {"NLM": "Taveira-DaSilva AM, Moss J. Management of lymphangioleiomyomatosis F1000Prime Rep. 2014;6():116. PMID: 25580270", "BibTeX": "@article{25580270, title={Management of lymphangioleiomyomatosis}, author={Taveira-DaSilva AM and Moss J}, journal={F1000Prime Rep}, volume={6}, pages={116}}"}}, {"_id": "23035046", "pmid": 23035046, "title": "Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).", "journal": "Sci Transl Med", "authors": ["Goncharova EA", "Goncharov DA", "Fehrenbach M", "Khavin I", "Ducka B", "Hino O", "Colby TV", "Merrilees MJ", "Haczku A", "Albelda SM", "Krymskaya VP"], "date": "2012-10-03T00:00:00Z", "doi": "10.1126/scitranslmed.3003840", "meta_date_publication": "2012 Oct 3", "meta_volume": "4", "meta_issue": "154", "meta_pages": "154ra134", "score": 50085.938, "text_hl": "Our findings demonstrate a mechanistic link between loss of @GENE_TSC2 @GENE_22084 @@@TSC2@@@ and @DISEASE_Liver_Cirrhosis_Biliary @DISEASE_MESH:D008105 @@@alveolar destruction@@@ and suggest that treatment with @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@rapamycin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ together could benefit @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Lymphangioleiomyomatosis</m> @DISEASE_MESH:D018192 @@@LAM@@@ by targeting cells with @GENE_TSC2 @GENE_7249 @@@TSC2@@@ dysfunction and preventing airspace enlargement.", "citations": {"NLM": "Goncharova EA, Goncharov DA, Fehrenbach M, Khavin I, Ducka B, Hino O, Colby TV, Merrilees MJ, Haczku A, Albelda SM, Krymskaya VP. Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM). Sci Transl Med. 2012 Oct 3;4(154):154ra134. PMID: 23035046", "BibTeX": "@article{23035046, title={Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM).}, author={Goncharova EA and Goncharov DA and Fehrenbach M and Khavin I and Ducka B and Hino O and Colby TV and Merrilees MJ and Haczku A and Albelda SM and Krymskaya VP}, journal={Sci Transl Med}, volume={4}, number={154}, pages={154ra134}}"}}, {"_id": "25167325", "pmid": 25167325, "title": "Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.", "journal": "Chest", "authors": ["Taveira-DaSilva AM", "Jones AM", "Julien-Williams PA", "Stylianou M", "Moss J"], "date": "2015-01-01T00:00:00Z", "doi": "10.1378/chest.14-0758", "meta_date_publication": "2015 Jan", "meta_volume": "147", "meta_issue": "1", "meta_pages": "180-187", "score": 50085.3, "text_hl": "Retrospective review of combined @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@sirolimus@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ therapy in @<m>DISEASE_Lymphangioleiomyomatosis</m> @DISEASE_MESH:D018192 @@@lymphangioleiomyomatosis@@@.", "citations": {"NLM": "Taveira-DaSilva AM, Jones AM, Julien-Williams PA, Stylianou M, Moss J. Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis. Chest. 2015 Jan;147(1):180-187. PMID: 25167325", "BibTeX": "@article{25167325, title={Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.}, author={Taveira-DaSilva AM and Jones AM and Julien-Williams PA and Stylianou M and Moss J}, journal={Chest}, volume={147}, number={1}, pages={180-187}}"}}, {"_id": "25980593", "pmid": 25980593, "title": "Lymphangioleiomyomatosis: New Treatment Perspectives.", "journal": "Lung", "authors": ["Radzikowska E"], "date": "2015-08-01T00:00:00Z", "doi": "10.1007/s00408-015-9742-6", "meta_date_publication": "2015 Aug", "meta_volume": "193", "meta_issue": "4", "meta_pages": "467-75", "score": 50078.832, "text_hl": "The article discussed the new control studies with mTOR inhibitors, @CHEMICAL_Doxycycline @CHEMICAL_MESH:D004318 @@@doxycycline@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, and combination of them in @<m>DISEASE_Lymphangioleiomyomatosis</m> @DISEASE_MESH:D018192 @@@LAM@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Radzikowska E. Lymphangioleiomyomatosis: New Treatment Perspectives. Lung. 2015 Aug;193(4):467-75. PMID: 25980593", "BibTeX": "@article{25980593, title={Lymphangioleiomyomatosis: New Treatment Perspectives.}, author={Radzikowska E}, journal={Lung}, volume={193}, number={4}, pages={467-75}}"}}, {"_id": "23947572", "pmid": 23947572, "title": "Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling.", "journal": "Am J Respir Cell Mol Biol", "authors": ["Atochina-Vasserman EN", "Goncharov DA", "Volgina AV", "Milavec M", "James ML", "Krymskaya VP"], "date": "2013-11-01T00:00:00Z", "doi": "10.1165/rcmb.2013-0203RC", "meta_date_publication": "2013 Nov", "meta_volume": "49", "meta_issue": "5", "meta_pages": "704-9", "score": 50070.445, "text_hl": "These findings have translational significance for combinatorial therapeutic strategies of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to inhibit @GENE_TSC2 @GENE_7249 @@@TSC2@@@-null cell survival in @DISEASE_Tuberous_Sclerosis @DISEASE_MESH:D014402 @@@TS@@@ and @<m>DISEASE_Lymphangioleiomyomatosis</m> @DISEASE_MESH:D018192 @@@LAM@@@.", "citations": {"NLM": "Atochina-Vasserman EN, Goncharov DA, Volgina AV, Milavec M, James ML, Krymskaya VP. Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling. Am J Respir Cell Mol Biol. 2013 Nov;49(5):704-9. PMID: 23947572", "BibTeX": "@article{23947572, title={Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling.}, author={Atochina-Vasserman EN and Goncharov DA and Volgina AV and Milavec M and James ML and Krymskaya VP}, journal={Am J Respir Cell Mol Biol}, volume={49}, number={5}, pages={704-9}}"}}]}